Gabapentin Tablet
Product Images NDC 72162-1531

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This text appears to be describing a study or experiment involving the evaluation of pain scores over a period of seven weeks. The study involves three different doses, including a placebo and two doses of gabapentin (1800 mg/day and 2400 mg/day). The pain scores are measured at baseline and then at weekly intervals for the duration of seven weeks.*
FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Image-04 (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Label (Lbl721621531)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.